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Alzheimer's disease is one of the main causes of dementia in the
elderly and its frequency is on the rise worldwide. It is considered
the result of complex interactions between genetic and environ-
mental factors, being many of them unknown. Therefore, there is a
dire necessity for the identiﬁcation of novel molecular players for
the understanding of this disease. In this data article wevier Inc. This is an open access article under the CC BY license
/j.jprot.2016.03.022
+52 55 57473800 x5567; fax: +52 55 57473393.
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B. Minjarez et al. / Data in Brief 7 (2016) 1707–17191708determined the protein expression proﬁles of whole protein
extracts from cortex regions of brains from patients with Alzhei-
mer's disease in comparison to a normal brain. We identiﬁed 721
iTRAQ-labeled polypeptides with more than 95% in conﬁdence. We
analyzed all proteins that changed in their expression level and
located them in the KEGG metabolic pathways, as well as in the
mitochondrial complexes of the electron transport chain and ATP
synthase. In addition, we analyzed the over- and sub-expressed
polypeptides through IPA software, speciﬁcally Core I and Bio-
markers I modules. Data in this article is related to the research
article “Identiﬁcation of proteins that are differentially expressed
in brains with Alzheimer’s disease using iTRAQ labeling and tan-
dem mass spectrometry” (Minjarez et al., 2016) [1].
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Cell Biology
ore speciﬁc sub-
ject areaAlzheimer's diseaseype of data Tables, ﬁgures
ow data was
acquiredIsobaric labeling, preparative isoelectrofocusing, reverse phase chromato-
graphy, and tandem mass spectrometry using an AB SCIEX high performance
hybrid quadrupole time-of-ﬂight QSTAR ESI XL Hybrid LC/MS/MS Mass
Spectrometer Systemata format Analyzed and ﬁltered
xperimental
factorsSamples were reduced, alkylated and digested with 50 mM TCEP, 200 mM
MMTS, and sequencing grade Trypsin, respectively, and iTRAQ-labeled
according to the protocol described in the manual of the iTRAQ 8-plex kit,
with minor modiﬁcationsxperimental
featuresPeptides were labeled, pooled and separated by isoelectrofocusing on a non-
linear pH 3-10 gradient. Strips were divided in sections, and peptides
extracted were chromatographed in a C18 column using several ACN linear
gradients and analyzed by MS/MS. Identiﬁed proteins were grouped and
classiﬁed with IPA and KEGG software, as well as analyzed in IntAct and
BioGRID databasesata source
locationMexico City, Mexicoata accessibility Data is within this articleValue of the data
 Data provide the whole list of proteins identiﬁed in brains with Alzheimer's disease and their
expression levels in comparison to a normal brain.
 Data provide information of over- and sub-expressed polypeptides found in common in all
Alzheimer's disease brains in relation to diseases and biofunctions in which they might be
involved according to IPA database.
 Data can be used in further studies to gain insight into the different affected pathways or networks,
or into the role of each identiﬁed protein using cellular or whole organism models of Alzheimer's
disease.
B. Minjarez et al. / Data in Brief 7 (2016) 1707–1719 1709 Data provide insight of putative biomarkers found in Alzheimer's disease brains and open the
possibility to explore their expression level in a bigger number of brains with Alzheimer's disease
in comparison to normal brains to validate them as possible biomarkers, as well as in serum of CSF
samples.1. Data
The data provides a list of identiﬁed 721 iTRAQ-labeled proteins with at least one peptide with
Z95% in conﬁdence (Table 1). Polypeptides that changed in their expression levels were classiﬁed
according to diseases and biofunctions with the IPA software (Table 2) and analyzed with IPA Core I
into different functional networks (Figs. 1–3). We included the mapping of proteins with differential
expression into metabolic (Fig. 4) and oxidative phosphorylation (Fig. 5) processes, and determined
different interaction networks using IntAct (Figs. 6 and 9) and BioGRID (Figs. 7, 8 and 10–13)
databases.Activation
Inhibition
Fig. 1. IPA functional network of differentially expressed proteins found in all brains with Alzheimer's disease through IPA Core
I analyses related with (i) Free Radical Scavenging, (ii) Neurological Disease, (iii) Cancer, and (iv) Cell Death and Survival.
Different shapes, indicating the functional class to which they belong, represent proteins. Molecules in red are overexpressed
polypeptides, whilst those green molecules correspond to subexpressed proteins. IPA incorporated molecules in grey, which
are not speciﬁed, into the networks through relationships with other molecules. Molecular relationships between polypeptides
are indicated with lines. A continuous line illustrates a direct interaction and a dotted line is used for indirect interactions.
Proteins, whose expression is age-dependent, are labeled with a star (red and blue for over- and sub-expressed, respectively).
Activation
Inhibition
Fig. 2. IPA functional network of differentially expressed proteins found in all brains with Alzheimer's disease through core I
analyses related with (i) Cell Death and Survival, (ii) Cellular Movement, (iii) Cancer, (iv) Cellular Growth and Proliferation,
(v) Tissue Morphology, (vi) Hematological System Development and Function, (vii) Immune Cell Trafﬁcking, and (viii) Organ
Morphology. Different shapes, indicating the functional class to which they belong, represent proteins. Molecules in red are
overexpressed polypeptides, whilst those green molecules correspond to subexpressed proteins. IPA incorporated molecules in
grey, which are not speciﬁed, into the networks through relationships with other molecules. Molecular relationships between
polypeptides are indicated with lines. A continuous line illustrates a direct interaction and a dotted line is used for indirect
interactions.
B. Minjarez et al. / Data in Brief 7 (2016) 1707–171917102. Experimental design, materials and methods
The analyses performed in this data article were focused on the over- or sub-expressed proteins
that changed in their expression level in Z15% or r15%, respectively.2.1. IPA Core Analysis of proteins that changed in their expression level in all Alzheimer's disease brains
For the classiﬁcation of identiﬁed overexpressed and subexpressed proteins in all Alzheimer's
disease brains [1] in diseases and biological functions, canonical pathways, molecular networks and
the selection of putative candidates for biomarkers, we used the module Core Analysis and Bio-
markers ﬁlter of the full version of the Ingenuity Pathway Analysis software (IPA, QIAGEN's Redwood
City, www.qiagen.com/ingenuity). We performed one analysis named Core I. In this analysis we used
tissues and primary cells, including nervous system, organ systems, and other tissues and primary
cells. The ﬁlter also included cell lines of Central Nervous System (CNS), neuroblastoma, leukemia,
osteosarcoma, melanoma, lymphoma, immune system, macrophage, lung, breast, hepatoma, pan-
creatic, kidney, myeloma, ovarian, cervical, prostate, teratocarcinoma and colon cancer, and other cell
Activation
Inhibition
Fig. 3. IPA functional network of differentially expressed proteins found in all brains with Alzheimer's disease through core I
analyses related with (i) Cellular Movement, (ii) Cellular Growth and Proliferation, (iii) Cell Death and Survival, (iv) Cancer, and
(v) Gastrointestinal Disease. Different shapes, indicating the functional class to which they belong, represent proteins. Mole-
cules in red are overexpressed polypeptides, whilst those green molecules correspond to subexpressed proteins. Molecules in
grey, which are not speciﬁed, were incorporated into the networks by IPA through relationships with other molecules.
Molecular relationships between polypeptides are indicated with lines. A continuous line illustrates a direct interaction and a
dotted line is used for indirect interactions.
Fig. 4. Global view of the metabolic pathways of the KEGG database that were affected in brains with Alzheimer's disease. The
overexpressed proteins are represented in red color and the subexpressed polypeptides in green. Those proteins whose
expression is age-dependent are in red (overexpressed) and blue (subexpressed) rectangles (see Table 1 and 2 in [1]).
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Fig. 5. Localization of subexpressed proteins in the oxidative phosphorylation process obtained from the KEGG database. The
localization of the subexpressed polypeptides in each complex of the respiratory chain is indicated in brilliant green color. We
also show in brilliant green the subunits of the V-ATPase that were found subexpressed. Proteins, whose expression is age-
dependent, are labeled with a black star (see Table 2 in [1]).
Fig. 6. Interactions maps determined in the IntAct Molecular Interaction Database for the set of overexpressed proteins in
brains with Alzheimer's disease (see Table 1 in [1] for data).
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Fig. 7. Interactions experimentally determined for the overexpressed High Mobility Group Box 1 protein (HMGB1, UniProtKB ID
P09429) in brains with Alzheimer's disease in BioGRID database.
B. Minjarez et al. / Data in Brief 7 (2016) 1707–1719 1713lines, using a stringent ﬁlter. The Fisher's Exact Test was employed for the determination of the p-
value. It was considered as signiﬁcant with values lower than 0.05. Analysis included the following
parameters: (1) Ingenuity Knowledge Base (genes only), considering direct and indirect relationships.
(2) Interaction networks including endogenous chemicals, default value of 35 molecules per network
and 25 networks per analysis. (3) All data source. (4) Conﬁdence: experimentally observed, highly and
moderately predicted. (5) Human species with stringent ﬁlter. (6) All mutations.2.2. IPA biomarker analysis
In order to select some putative biomarkers, we ﬁltered all selected proteins through IPA software
using only the Biomarkers I analyses. The parameters of Biomarkers ﬁlter I included all tissues and
primary cells, and all cell lines, all diseases and all biomarkers application, and biomarkers diseases. It
also included the following parameters: (1) human species, (2) all molecules type, and (3) all
bioﬂuids.
Fig. 8. Interactions experimentally determined for the overexpressed NAD-dependent deacetylase sirtuin-2 protein (SIRT2,
UniProtKB ID Q8IXJ6) in brains with Alzheimer's disease in BioGRID database.
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Fig. 9. Interactions maps determined in the IntAct Molecular Interaction Database for the set of subexpressed proteins in
brains with Alzheimer's disease (see Table 2 in [1] for data).
Fig. 10. Interactions experimentally determined for the subexpressed Sideroﬂexin-1 protein (SFXN1, UniProtKB ID Q9H9B4) in
brains with Alzheimer's disease in BioGRID database.
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Fig. 11. Interactions experimentally determined for the subexpressed Transforming protein RhoA or Ras homology family
member A (RHOA, UniProtKB ID P61586) in brains with Alzheimer's disease in BioGRID database.
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Fig. 12. Interactions experimentally determined for the Disks large homolog 4 protein (DLG4, UniProtKB ID P78352) in brains
with Alzheimer's disease in BioGRID database.
B. Minjarez et al. / Data in Brief 7 (2016) 1707–1719 17172.3. Bioinformatics analyses in KEGG, IntAct and BioGRID databases
The proteins that showed a change in their expression levels in the three AD brains were mapped
in the biochemical pathways of the Kyoto Encyclopedia of Genes and Genomes (KEGG) (http://www.
genome.jp/kegg/). For the determination of interactions maps, sets of overexpressed and sub-
expressed proteins were submitted for their analysis to the IntAct Molecular Interaction Database at
the European Bioinformatics Institute (http://www.ebi.ac.uk/intact/) [2]. To identify interactors that
have been experimentally identiﬁed for selected overexpressed and subexpressed proteins, their IDs
were submitted to the BioGRID database (Biological General Repository for Interaction Datasets,
http://thebiogrid.org/) [3], using the current index version 3.4.133.
Fig. 13. Interactions experimentally determined for the solute carrier family 1 (glial high afﬁnity glutamate transporter),
member 2, also known as Excitatory amino acid transporter 2 (SLC1A2, UniProtKB ID P43004) in brains with Alzheimer's
disease in BioGRID database.
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